Delivery Order SPE2DR25D1041-SPE2DR26FHP7P
- Not listed
- This federal contract award, valued at $1,493.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,568,201,898 units of Diclofenac Sodium Delayed-Release 75 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Diclofenac Potassium 50 mg tablets (100-count units) with a ceiling value of $4,175.22. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel (100GM) with a ceiling value of $1,466.40. This non-competitive, firm fixed-price delivery order was executed on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Diclofenac Sodium 1% Gel (100 grams) with a ceiling value of $1,242.72 on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-competitive delivery order employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction supporting the federal medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.27, is for the delivery of 100 mg tablets of the drug diclofenac sodium extended-release. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2023. The contract is not designated with a set-aside....
- The Defense Logistics Agency awarded a $1,272.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 50-0.2 mg tablets (60-count units) on July 31, 2025, with completion scheduled for August 1, 2025. This award was not designated as a set-aside contract and represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp received a $1,194.93 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on March 18, 2025, for Diclofenac-Misoprostol 75-0.2 mg tablets (60-count supply). The contract, which is neither set-aside nor restricted, has an ultimate completion date of March 19, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,219.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 75-0.2 mg tablets (60-count) on May 30, 2025, with a completion date of June 2, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be fulfilled from the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Diclofenac Sodium 1% Gel in 100-gram units, with a ceiling value of $1,173.12. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,462.54, is for the delivery of 100 mg diclofenac sodium extended-release tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DR25D1041Indefinite Delivery Contract
- SPE2DR25D1041-SPE2DR26FHP7PDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Diclofenac Sodium Delayed Release 75 mg tablets (500 count) with a contract value of $1,250.20. This firm fixed price delivery order, which is not set aside for any specific business category, is scheduled for completion by October 23, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a significant federal contracting presence as a critical vendor for military and veteran healthcare procurement. The company's extensive portfolio with the Defense Logistics Agency encompasses delivery of various pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This award reflects the company's demonstrated capability to meet federal procurement requirements through competitive selection and its role as a key supplier within the Defense Health Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/22/25 |